ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,970.84
0.00%
US Tech 100
20,677.20
-1.08%
Dow Jones
42,992.21
0.00%
Brent Oil
74.035
0.56%
Bitcoin
92,992.93
-0.56%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. IGC Pharma Inc (IGC)

  7. IGC Pharma Inc (IGC) News

IGC Pharma Inc

IGC Pharma Inc (IGC)

India Capital Growth Fund Limited
0.37
0.002
(0.54%)
Closed December 27 4:00PM
Delayed by 15 minutes
0.3739
0.0039
( 1.05% )
Pre Market: 8:23AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

IGC News

Official News Only

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
February 14 2024
IGC (0.54%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
January 31 2024
IGC (0.54%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
January 09 2024
IGC (0.54%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
December 29 2023
IGC (0.54%)

IGC Discussion

View Posts
georgie18 georgie18 2 weeks ago
IGC...4138...🥳Off the 3897 Alert...

georgie18

Member Level
Re: None

Wednesday, December 11, 2024 1:17:54 PM

Post#
667553
of 667765
IGC...3897...🥳Scaling in here... New trials to evaluate IGC-AD1's potential impact on amyloid plaque, tau tangles, and cognitive decline in Alzheimer's diseaseExpanded research positions IGC-AD1 as a potential treatment targeting the underlying disease pathology of Alzheimer's

POTOMAC, MARYLAND / ACCESSWIRE / December 2, 2024 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today an expansion of its clinical research program for IGC-AD1, an investigational treatment for Alzheimer's disease. Building on Phase 2 interim results demonstrating reductions in agitation and cognitive improvement, the Company is initiating new trials to evaluate IGC-AD1's potential as a disease-modifying therapy.

The expanded research will explore how IGC-AD1's dual-action mechanism-combining anti-neuroinflammatory properties with amyloid- and tau-targeting effects-may slow the progression of Alzheimer's disease. These trials will evaluate critical outcomes, including cognitive function and biological markers associated with Alzheimer's, such as amyloid and tau levels, at multiple time points. Building on previously announced preclinical data showing IGC-AD1's impact on amyloid plaques and spatial memory, these investigations aim to explore its potential to influence key pathological features of Alzheimer's disease.

"We plan to initiate a new Phase 2 clinical trial for IGC-AD1 in 2025," said Ram Mukunda, CEO of IGC Pharma. "The trial underscores our commitment to advancing IGC-AD1 as a potential disease-modifying therapy for Alzheimer's. Cognitive decline is one of the most devastating aspects of Alzheimer's, severely impacting patients' memory, attention, and reasoning. By focusing on cognitive outcomes and underlying disease mechanisms such as amyloid plaques and tau tangles, we aim to address the critical unmet needs of patients and caregivers. This subsequent research phase is a significant step forward in delivering innovative treatments to those who need them most.

These new trials represent a pivotal step in advancing IGC-AD1 as a transformative Alzheimer's treatment. By exploring its potential as a disease-modifying therapy, we aim to create opportunities for strategic partnerships and licensing with major pharmaceutical companies. Our vision is to deliver innovative therapies that address the immense challenges faced by patients and caregivers while generating substantial value for our investors."
👍️0
georgie18 georgie18 3 weeks ago
IGC...3897...🥳Scaling in here... New trials to evaluate IGC-AD1's potential impact on amyloid plaque, tau tangles, and cognitive decline in Alzheimer's diseaseExpanded research positions IGC-AD1 as a potential treatment targeting the underlying disease pathology of Alzheimer's

POTOMAC, MARYLAND / ACCESSWIRE / December 2, 2024 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today an expansion of its clinical research program for IGC-AD1, an investigational treatment for Alzheimer's disease. Building on Phase 2 interim results demonstrating reductions in agitation and cognitive improvement, the Company is initiating new trials to evaluate IGC-AD1's potential as a disease-modifying therapy.

The expanded research will explore how IGC-AD1's dual-action mechanism-combining anti-neuroinflammatory properties with amyloid- and tau-targeting effects-may slow the progression of Alzheimer's disease. These trials will evaluate critical outcomes, including cognitive function and biological markers associated with Alzheimer's, such as amyloid and tau levels, at multiple time points. Building on previously announced preclinical data showing IGC-AD1's impact on amyloid plaques and spatial memory, these investigations aim to explore its potential to influence key pathological features of Alzheimer's disease.

"We plan to initiate a new Phase 2 clinical trial for IGC-AD1 in 2025," said Ram Mukunda, CEO of IGC Pharma. "The trial underscores our commitment to advancing IGC-AD1 as a potential disease-modifying therapy for Alzheimer's. Cognitive decline is one of the most devastating aspects of Alzheimer's, severely impacting patients' memory, attention, and reasoning. By focusing on cognitive outcomes and underlying disease mechanisms such as amyloid plaques and tau tangles, we aim to address the critical unmet needs of patients and caregivers. This subsequent research phase is a significant step forward in delivering innovative treatments to those who need them most.

These new trials represent a pivotal step in advancing IGC-AD1 as a transformative Alzheimer's treatment. By exploring its potential as a disease-modifying therapy, we aim to create opportunities for strategic partnerships and licensing with major pharmaceutical companies. Our vision is to deliver innovative therapies that address the immense challenges faced by patients and caregivers while generating substantial value for our investors."
👍️0
TheFinalCD TheFinalCD 4 months ago
https://finance.yahoo.com/news/igc-pharma-expands-drug-portfolio-120000131.html
👍️0
Smilin_B Smilin_B 9 months ago
Looks like Bradbury is unleashing some of its shares into the market

On March 22, 2024, the Company entered into a Share Purchase Agreement (the "SPA") with Bradbury, subject to the terms and subject to the conditions set forth in the SPA. The investment is for approximately $3 million in gross proceeds at the March 21, 2024, closing price of $0.34. The funds will support general corporate purposes and the Company's advancement of its investigational medicines including IGC-AD1.

The completion of the private placement is subject to customary closing conditions, including approval by the NYSE. Under the terms of the SPA, IGC will issue 8,823,529 shares of common stock. The shares are unregistered and are not immediately tradable.

🤥 1 🧌 1
ErnieBilco ErnieBilco 9 months ago
Vamos a ver quien esta correcto


We will see who is right.
👍️0
malata malata 9 months ago
Creo que esta todo claro , nos vamos otra vez para abajo , lo que decian que iriamos a los 2 o mas nada de nada
👍️0
ErnieBilco ErnieBilco 9 months ago
Creo que entre $2 y $6 por ahora, si algo mas paso vamos hacer nuevo target del precio.

Solo es mi idea nada mas

Translation: I think between $2 to $6 unless something more happens, then would have to pick a new target.

JMO
👍️0
malata malata 9 months ago
Hola , hasta donde cree que puede llegar ? he visto que la sigue y esta muy activo en con los mensajes . Gracias
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
IGC HERE COMES .80C
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
IGC...READY FOR 80C
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
IGC..TRENDING IN THE 70S NOW
👍️0
gail gail 9 months ago
that was quite the pop, indeed!
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
IGC after hours pop
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
IGC...BREAKING OUT
👍️ 1
TrendTrade2016 TrendTrade2016 9 months ago
IGC...GET OUT OF THE WAY ARCA...YA MAGGOT
👍️0
TrendTrade2016 TrendTrade2016 9 months ago
IGC...BIO BEAST SETTING UPI TO BEAST
👍️0
oak4life20 oak4life20 9 months ago
Yes 🙌🏿✊🏿
👍️0
ErnieBilco ErnieBilco 9 months ago
Ohhhh it's so peaceful without ANY pumper on board - Love it when a stock moves without the hub.
👍️0
ErnieBilco ErnieBilco 9 months ago
So the private placement is already a done deal at .34 which is where I placed my first buy so this really shouldn't drop tomorrow but if it does I'll be ready to scoop up what I can at my down price bid already set.

LET' S SEE HOW THIS PLAYS TOMORROW.
👍️0
ErnieBilco ErnieBilco 9 months ago
Looks like peeps are starting to digest the possibilities $IGC presents. Great time to jump on board to see where this ride goes from here.
👍️0
ErnieBilco ErnieBilco 9 months ago
– Interim Data: Study Achieves Primary End Point Demonstrating Clinical and Statistically Significant Reductions Compared to Placebo in Agitation Associated with Dementia Due to Alzheimer’s Disease –

Potomac, MD, March 20, 2024 – IGC Pharma, Inc. (“IGC Pharma”, “IGC”, or the “Company”) (NYSE American: IGC) today announced the results of an interim analysis of its ongoing Phase 2 trial investigating IGC-AD1 as a treatment for Agitation in dementia from Alzheimer’s Disease (“AAD”).

The interim data demonstrates a clinical and statistically significant reduction in agitation compared to placebo in patients with Alzheimer’s disease, indicating strong therapeutic potential for IGC-AD1.

The study’s primary goal is to assess the change in AAD after six weeks using a standard scale, the Cohen Mansfield Agitation Inventory (“CMAI”). Based on interim data, patients taking IGC-AD1, on average, experienced a more significant reduction in agitation scores compared to those on placebo, and the positive effects were observed as early as week two of the trial.
👍️0
ErnieBilco ErnieBilco 9 months ago
I have my target entry point - let's see if it hits.
👍️0
ErnieBilco ErnieBilco 9 months ago
Positive news out on drug candidate
👍️0
ErnieBilco ErnieBilco 9 months ago
Looking to pick up a starter here
👍️0
ErnieBilco ErnieBilco 9 months ago
Board needs a name change to reflect the new operations.
👍️0
Smilin_B Smilin_B 3 years ago
All these months i never understood WHO was propping these bs shares up over $1

Now it makes sense

.45 of them
👍️0
Porterhouse10 Porterhouse10 3 years ago
Not in this, but had a watch on it, have low $8's in GRWG
👍️0
Pennyes Pennyes 3 years ago
Yes!, with or without the vote Cannabis/Hemp sector is ripe for a breakout that is what is happening,

the legalization news just came and it is going to add more fuel to the huge breakout!..
👍️0
Porterhouse10 Porterhouse10 3 years ago
Big Vote next week, many movers in Sector
👍️0
Pennyes Pennyes 3 years ago
IGC breakout alert and 10% move up, just the ignition to the rally!? Isn't that a spot on "breakout alert" or what?. Well, almost all (more than 90% of my alerts) goes through a spot on results!..


Target price: $1.10, $2 and $5, all these are near term to short term targets spanning days, weeks to just couple of months!.
👍️0
Pennyes Pennyes 3 years ago
maintained a few small numbers for a long time, yesterday I nailed it when I saw the bottom!!..this will skyrocket for sure, but people must do their own research DDs! and make use of the opportunity in breakouts!
👍️0
Smilin_B Smilin_B 3 years ago
I have no position here. It has been on my watch list for about a decade
👍️0
Pennyes Pennyes 3 years ago
Agree with your second half, scammer CEO, but the company came long way now, he seems to be still on top of the management, but sales, products and research pipelines using cannabis/cbd are progressing, hard to believe but it is happening!.

the stupid stock price and poor performance is a industry/or Sector wide manipulation, nothing to do with how this co managed etc!.

and that is going to change now, as the sector reached a boiling point of exploding out of this manipulators control!, and every stock, good, bad, ugly will skyrocket...

you can take it or leave it, that is destined to happen!.

Enjoy the ride!
👍️0
Smilin_B Smilin_B 3 years ago
You do realize I've been here since Inception when this was an iron ore mining company with scam artist Ram Mukunda as CEO
👍️0
Pennyes Pennyes 3 years ago
Really!?...is that your discovery, time well spent and that "Nobody" is you alone or are there some more!?..
👍️0
Smilin_B Smilin_B 3 years ago
Nobody even knows what the hell this piece of shit company does
👍️0
Pennyes Pennyes 3 years ago
alright folks, check my breakout alert, previous post!.
👍️0
Pennyes Pennyes 3 years ago
Stop removing mods...
👍️0
Pennyes Pennyes 3 years ago
ihubs ridiculous removing mods got to stop, this is a bs policy! so much time is sucked up and go waste in putting up a board, morons remove it at their whims!.
👍️0
Pennyes Pennyes 3 years ago
Notorious "inverted Cup & Handle" is coming to an End!....IGC juar Bottomed!.

and that's got to change the status of IGC trading and performance, cannot imagine how notoriously manipulated all the cannabis/hemp related stocks!, but there is always a limit to what they can do and a Breakout out will smash and toast the MMs, shorties and everyone else is screwing up this stock...and the time is Now!..

Enjoy the ride, in my next post I will provide target prices, it will be juicy and nice!.
👍️0
Smilin_B Smilin_B 3 years ago
One thing I will never understand is HOW IS THIS STOCK TRADING SUCH ELEVATED VOLUME EVERY SINGLE DAY YET IS NEVER A TOPIC OF DISCUSSION ON ANY FORUMS?

👍️0
Smilin_B Smilin_B 3 years ago
How the hell does this stock trade so much in volume yet get hardly any conversation whatsoever?
👍️0
Biggeoff Biggeoff 3 years ago
Carl Icahn is investing
👍️0
Dengxiaoping Dengxiaoping 3 years ago
To understand the CEO you have to understand the Fraud Culture of India. https://www-dailyo-in.cdn.ampproject.org/v/s/www.dailyo.in/lite/variety/scams-nirav-modi-rotomac-fodder-scam-pnb/story/1/22537.html?amp_js_v=a6&_gsa=1&usqp=mq331AQKKAFQArABIIACAw%3D%3D#aoh=16295815347950&_ct=1629581554362&referrer=https%3A%2F%2Fwww.google.com&_tf=From%20%251%24s&share=https%3A%2F%2Fwww.dailyo.in%2Fvariety%2Fscams-nirav-modi-rotomac-fodder-scam-pnb%2Fstory%2F1%2F22537.html
👍️0
Troytex Troytex 3 years ago
Yep I agree..may consider buying ,a hundred shares I long term,a jyear or. More if I trsearch other patents for skin issues arthritis ,parkensens etc..will post result soon
👍️0
geocam geocam 3 years ago
It bounced at the open then fell for the remainder. Might see another bounce off 1.60's but 1.40-1.50 looks like better entry.
👍️0
Troytex Troytex 3 years ago
No bounce today..extra research shows igc had reverse 10 for 1 stock split.. in 2013…it’s been downhill except for couple spikes from “fake” news reports . plus given. their ultra high cost per employee..ie nonprofit for 4 years ago, I suggest owners and insiders are exceptionally poor manager or they are 99% dishonest and only see stock as a way to line their pockets..wow..am glad I only bought 150 shares..if it gets to $2.20 I will sell ASAP.Troytex in north Texas
👍️0
geocam geocam 3 years ago
$IGC Watching for Monday Morning Bounce.

Shs Outstand 45.11M
Shs Float 28.06M
Short Float 11.05%
Short Ratio 43.00%

52W Range 0.54 - 4.65

Rel Volume 3.22
Avg Volume 7.18M
Volume 23,141,915

https://finviz.com/quote.ashx?t=IGC&ty=c&p=d&b=1






👍️0
Troytex Troytex 3 years ago
Is igc a scam…in past 5 years…yeah I kind of agree..however recently with us govt patent “seems” like good news..in past 4 or 5 years it was rather shady..I bet most, maybe 90% of would be investors never look past the rosy new media releases…hence why I bought a few shares at $1.91… next time possible/positive news release comes I can sell a few shares and make lunch money for a day or two…will post my research on university of Florida and us gov patents on Monday…Summary buyer beware.. Troytex in north Texas Friday July 23, 2021.
👍️0
shimanoman shimanoman 3 years ago
IGC is a 100 % scam “company” has anyone bothered to google their “headquarters” in Maryland?? Lol you might get a laugh.. its a rickety old house with wall mounted AC units hanging out of it!! Maybe 1,400 sq ft of a dump.
👍️0

Your Recent History

AMEX
IGC
IGC Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads